WallStSmart
RVPH

Reviva Pharmaceuticals Holdings Inc.

NASDAQ: RVPH · HEALTHCARE · BIOTECHNOLOGY

$0.87
+0.43% today

Updated 2026-04-30

Market cap
$11.68M
P/E ratio
P/S ratio
EPS (TTM)
$-5.48
Dividend yield
52W range
$1 – $23
Volume
1.6M

Reviva Pharmaceuticals Holdings Inc. (RVPH) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-50.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-283.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.3%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+22.7%
2026-03-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.57$0.66$0.81+22.7%
2026-03-23$-5.19-7179.1%$0.80$0.83+3.4%
2025-11-13$-0.06+40.0%$0.58$0.50-13.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.57
2025-12-31$-0.07$-5.19-7179.1%
2025-09-30$-0.10$-0.06+40.0%
2025-06-30$-0.13$-0.12+7.7%
2025-03-31$-0.18$-0.15+18.0%
2024-12-31$-0.23$-0.90-300.0%
2024-09-30$-0.25$-0.25+0.0%
2024-06-30$-0.29$-0.26+10.3%
2024-03-31$-0.38$-0.25+34.2%
2023-12-31$-0.35$-0.35+0.0%
2023-09-30$-0.37$-0.44-18.9%
2023-06-30$-0.28$-0.55-96.4%

Frequently asked questions

Has Reviva Pharmaceuticals Holdings Inc. beaten earnings estimates?
Reviva Pharmaceuticals Holdings Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -50.8% over the last 3 quarters.
How does RVPH stock react to earnings?
RVPH stock has moved an average of +4.3% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.